Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $54.60 MXN
Change Today -0.40 / -0.73%
Volume 401.8K
MEDICAB On Other Exchanges
As of 4:09 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

medica sur s.a.b. - ser b (MEDICAB) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/25/14 - $59.90
52 Week Low
05/30/14 - $44.20
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDICA SUR S.A.B. - SER B (MEDICAB)

Related News

No related news articles were found.

medica sur s.a.b. - ser b (MEDICAB) Related Businessweek News

No Related Businessweek News Found

medica sur s.a.b. - ser b (MEDICAB) Details

Médica Sur, S.A.B. de C.V. operates as a teaching hospital that integrates various specialized medical care units, diagnostic, research, teaching, and social work activities in Mexico. The company provides health services in various areas, including laboratory, endoscopy, radiotherapy, alimentary behavior disorders, surgery, pathology, cardiology, clinic, foot and ankle, gastroenterology and morbid obesity, imaging, magnetic resonance imaging, metabolism, overweight and obesity, neonatology, neurophysiology, nuclear medicine, gynecology and obstetrics, pediatrics, physical therapy medicine, and woman treatment. It also offers blood bank and transfusion medicine, and medical tourism services; and operates centers for diagnosis and treatment, cancer, and integrated radiosurgery, as well as pharmacies and hotels. The company is based in Mexico City, Mexico.

medica sur s.a.b. - ser b (MEDICAB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medica sur s.a.b. - ser b (MEDICAB) Key Developments

Medica Announces Preliminary Non-Consolidated Earnings Results for the Fiscal Year 2014

Medica announced preliminary non-consolidated earnings results for the fiscal year 2014. For the year, the company announced that its preliminary non-consolidated net profit rose 28% over the year to BGN 2.1 million in 2014. Non-consolidated net sales revenues amounted to BGN 17.9 million last year, down by 6%. The company's non-consolidated operating profit jumped 63% to BGN 2.4 million in 2014.

Médica Sur, SAB de CV Presents at Deutsche Bank MX SMid Cap Forum, Jun-10-2014

Médica Sur, SAB de CV Presents at Deutsche Bank MX SMid Cap Forum, Jun-10-2014 . Venue: Deutsche Bank New York, 60 Wall Street - 26th Floor, New York, NY 10005, United States.

Médica Sur, SAB de CV(BMV:MEDICA B) dropped from SBF 120 Index

Médica Sur, SAB de CV will be removed to SBF 120 Index


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MEDICAB:MM $54.60 MXN -0.40

MEDICAB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MEDICAB.
View Industry Companies

Industry Analysis


Industry Average

Valuation MEDICAB Industry Range
Price/Earnings 22.2x
Price/Sales 3.0x
Price/Book 2.1x
Price/Cash Flow 22.1x
TEV/Sales 2.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICA SUR S.A.B. - SER B, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at